MONTELEONE, FABRIZIA

MONTELEONE, FABRIZIA  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.032 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2018 Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis Landi, D; Ragonese, P; Prosperini, L; Nociti, V; Haggiag, S; Cortese, A; Fantozzi, R; Pontecorvo, S; Ferraro, E; Buscarinu, Mc; Mataluni, G; Monteleone, F; Salvetti, M; Di Battista, G; Francia, A; Millefiorini, E; Gasperini, C; Mirabella, M; Salemi, G; Boffa, L; Pozzilli, C; Centonze, D; Marfia, Ga Articolo su rivista
1-nov-2018 Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course Stampanoni Bassi, M; Iezzi, E; Landi, D; Monteleone, F; Gilio, L; Simonelli, I; Musella, A; Mandolesi, G; De Vito, F; Furlan, R; Finardi, A; Marfia, Ga; Centonze, D; Buttari, F Articolo su rivista
1-nov-2018 Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course Stampanoni Bassi, M; Iezzi, E; Landi, D; Monteleone, F; Gilio, L; Simonelli, I; Musella, A; Mandolesi, G; De Vito, F; Furlan, R; Finardi, A; Marfia, Ga; Centonze, D; Buttari, F Articolo su rivista
1-gen-2017 Enhancing brain plasticity to contrast clinical progression in MS: a pilot study assessing the safety and efficacy of D-Aspartate Nicoletti, C; Monteleone, F; Marfia, G; Centonze, D; Mori, F Articolo su rivista
1-mar-2020 Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study Prosperini, L; Cortese, A; Lucchini, M; Boffa, L; Borriello, G; Buscarinu, Mc; Capone, F; Centonze, D; De Fino, C; De Pascalis, D; Fantozzi, R; Ferraro, E; Filippi, M; Galgani, S; Gasperini, C; Haggiag, S; Landi, D; Marfia, G; Mataluni, G; Millefiorini, E; Mirabella, M; Monteleone, F; Nociti, V; Pontecorvo, S; Romano, S; Ruggieri, S; Salvetti, M; Tortorella, C; Zannino, S; Di Battista, G Articolo su rivista
1-gen-2020 Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study Prosperini, L; Cortese, A; Lucchini, M; Boffa, L; Borriello, G; Buscarinu, Mc; Capone, F; Centonze, D; De Fino, C; De Pascalis, D; Fantozzi, R; Ferraro, E; Filippi, M; Galgani, S; Gasperini, C; Haggiag, S; Landi, D; Marfia, G; Mataluni, G; Millefiorini, E; Mirabella, M; Monteleone, F; Nociti, V; Pontecorvo, S; Romano, S; Ruggieri, S; Salvetti, M; Tortorella, C; Zannino, S; Di Battista, G Articolo su rivista
1-gen-2017 Fingolimod reduces the clinical expression of active demyelinating lesions in MS Signoriello, E; Landi, D; Monteleone, F; Nicoletti, C; Buttari, F; Sica, F; Marfia, G; Di Iorio, G; Lus, G; Centonze, D Articolo su rivista
5-feb-2018 Fingolimod reduces the clinical expression of active demyelinating lesions in MS Signoriello, E; Landi, D; Monteleone, F; Saccà, F; Nicoletti, C; Buttari, F; Sica, F; Marfia, G; Di Iorio, G; Lus, G; Centonze, D Articolo su rivista
10-dic-2013 Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis Basile, B; Castelli, M; Monteleone, F; Nocentini, U; Caltagirone, C; Centonze, D; Cercignani, M; Bozzali, M Articolo su rivista
1-lug-2019 The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) Grimaldi, Ae; De Giglio, L; Haggiag, S; Bianco, A; Cortese, A; Crisafulli, Sg; Monteleone, F; Marfia, G; Prosperini, L; Galgani, S; Mirabella, M; Centonze, D; Pozzilli, C; Castelli, L Articolo su rivista
1-gen-2017 Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain Monteleone, F; Nicoletti, Cg; Stampanoni Bassi, M; Iezzi, E; Buttari, F; Furlan, R; Finardi, A; Marfia, Ga; Centonze, D; Mori, F Articolo su rivista
7-feb-2019 Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis Nicoletti, Cg; Monteleone, F; Marfia, Ga; Usiello, A; Buttari, F; Centonze, D; Mori, F Articolo su rivista
3-set-2014 Reversible hyporegenerative anemia during natalizumab treatment Monteleone, F; Buccisano, F; Boffa, L; Buttari, F; DI VEROLI, A; Borriello, G; Rossi, S; Centonze, D Articolo su rivista
1-gen-2017 Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study Mirabella, M; Prosperini, L; Lucchini, M; Boffa, L; Borriello, G; Buscarinu, M; Centonze, D; Cortese, A; De Fino, C; De Giglio, L; Elia, G; Fantozzi, R; Ferraro, E; Francia, A; Galgani, S; Gasperini, C; Haggiag, S; Landi, D; Marfia, G; Millefiorini, E; Monteleone, F; Nociti, V; Salvetti, M; Sgarlata, E; Pozzilli, C Articolo su rivista
1-ago-2014 Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids Rossi, S; Motta, C; Studer, V; Boffa, L; De Chiara, V; Castelli, M; Barbieri, F; Buttari, F; Monteleone, F; Germani, G; Macchiarulo, G; Weiss, S; Centonze, D Articolo su rivista
1-nov-2019 Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis Nicoletti, Cg; Landi, D; Monteleone, F; Mataluni, G; Albanese, M; Lauretti, B; Rocchi, C; Simonelli, I; Boffa, L; Buttari, F; Mercuri, Nb; Centonze, D; Marfia, Ga Articolo su rivista
1-gen-2012 TRPV1 channels regulate cortical excitability in humans Mori, F; Ribolsi, M; Kusayanagi, H; Monteleone, F; Mantovani, V; Buttari, F; Marasco, E; Bernardi, G; Maccarrone, M; Centonze, D Articolo su rivista